VUB researcher wins Medtech Accelerator® 2020 Thursday 08/10/2020 VUB researcher Victor Grosu wins MedTech Accelerator 2020 with SMARCOS project Robots and humans are now able to work together to counter societal challenges such as the ageing population and the rising healthcare costs. Exoskeletons can help people to walk again, recover from injuries and compensate for disabilities. New innovative method to test paint Wednesday 07/10/2020 VUB revolutionises research into surface bonding With his doctoral research on the effect of paint layers on metal, Dr Sven Pletincx, supervised by Prof Tom Hauffman and Prof Herman Terryn of the VUB research group Electrochemical and Surface Engineering (SURF), has succeeded for the first time in investigating the effects of salts or water on the contact layer between paint and metal u… VUB becomes partner of CAPTURE (Centre for Advanced Process Technology for Urban REsource recovery) Wednesday 07/10/2020 Open marketplace for research, valorisation and training on resource recovery technologies CAPTURE brings together universities/research centres; companies; public organisations and governments to realize a multidisciplinary and intersectoral approach in tackling the need and added value for material recovery and re-use with a dedicated focus on water, CO2 and plastics. VUB/VIB scientist Damya Laoui receives Collen-Francqui Start-Up Grant Monday 05/10/2020 The Francqui Foundation has awarded the Collen-Francqui Start-Up Grant to VUB/VIB professor Damya Laoui. In addition to a financial allowance of €200.000, this three-year mandate also includes a research chair. This prestigious recognition will enable Prof Laoui to continue her award-winning research work into new immmunotherapies in fight against cancer. New VUB spin-off iCense studies people’s authentic emotions Wednesday 30/09/2020 Knowing what citizens and consumers really think of new measures, products or advertising is crucial for governments and businesses. But it is often difficult to find out. iCense, a new spin-off from the Vrije Universiteit Brussel, now offers neuro-research services that measure implicit emotional reactions and thus help to better understand and predict behaviour. Camel-IDS announces company name change to PRECIRIX® Monday 21/09/2020 Camel-IDS, VUB spin-off and a private, clinical-stage biotechnology company developing novel radiopharmaceuticals in oncology, today announces the launch of a new corporate identity and company name change to PRECIRIX®, effective immediately. Axiles Bionics and BruBotics receive €2M R&D grant from Innoviris Thursday 17/09/2020 One year after successfully completing a € 2.4M Series A financing round, Axiles Bionics announces a new R&D collaboration with BruBotics Research group from Vrije Universiteit Brussel to achieve its goal in developing a revolutionary next generation bionic prosthesis for lower limb amputees. Mobility expert Cathy Macharis released new book Tuesday 15/09/2020 VUB Professor Cathy Macharis released her new book called ‘Met een factor 8 naar de mobiliteit van de toekomst’, in which she highlights the impact of the transport sector on climate change and that the emissions should be reduced with a factor 8. Improving European healthcare through cell-based interceptive medicine Wednesday 09/09/2020 Hundreds of innovators, research pioneers, clinicians, industry leaders and policy makers from all around Europe are united by a vision of how to revolutionize healthcare. Four VUB researchers receive prestigious ERC Starting Grants Monday 07/09/2020 No fewer than four Vrije Universiteit Brussel researchers are receiving the European Commission's prestigious European Research Council Starting Grant this year. Togtether, the four grants total more than €6,3 mil. in research funds. Seppe Terryn finalist of the Flemish PhD Cup 2020 Monday 07/09/2020 Seppe is a PhD student at the VUB at the mechanical department in the Robotic & MultyBody (R&MM) research group, part of BruBotics. Healthier workplaces thanks to collaborative robotics Monday 31/08/2020 Across Europe, 40 million workers suffer from muscle, joint and nerve pain caused by physically demanding tasks. Moreover, such musculoskeletal disorders are the cause of as many as half of all absences in companies and therefore cost a great deal of money. Pages « First ‹ Previous … 20 21 22 23 24 (current) 25 26 27 28 … Next › Last »
